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Abstract
Pleomorphic adenoma (PA), originally called mixed tumour, is the most common neoplasm of the salivary glands 
and is generally accepted as benign biologically. Occasionally PA may give rise to metastasis. The metastasis may de-
velop in a PA in which a malignant transformation occurs, either arising a carcinoma in the PA (carcinoma ex-mixed 
tumour) or as a carcinosarcoma (so–called true malignant mixed tumour). However, very rare benign PA eventually 
metastasise, usually after having a previous recurrence, displaying benign histological features as well in the primary 
tumour as in the metastasis. These tumours have been termed metastatic PA or metastatic mixed tumours. The aim of 
this paper is to report one case of metastatic histological benign pleomorphic adenoma, and to consider the clinical, 
pathological and therapeutic consequences of these rare tumours as well as its possible causes and mechanisms for 
its behaviour.
Key words: Salivary, neoplasm, metastasis, adenoma, pleomorphic, surgery.
Indexed in: 
-Index Medicus / MEDLINE  /  PubMed            
-EMBASE, Excerpta Medica
-SCOPUS
-Indice Médico Español                                                        
-IBECS
              Article Number: 1111111495
              © Medicina Oral S. L. C.I.F. B 96689336 - ISSN 1698-6946 
              eMail:  medicina@medicinaoral.com 
Introduction
The pleomorphic adenoma is the most common tumour 
of glandular origin in the head and neck (1). In the 1991 
WHO classification of tumours of the salivary glands, the 
term "Malignant Mixed Tumour" comprises three diffe-
rent pathologies. These pathologies, which should not be 
confused, are the Carcinoma Ex Pleomorphic Adenoma 
(CEPA), the Carcinosarcoma (or True Malignant Mixed 
Tumour) and the Metastatic Mixed Tumour.
Malignant Mixed Tumours represent 3.6% of all neo-
plasms of the salivary glands and 12% of all malignant 
neoplasms of the salivary glands (2).
 Described by Kirklin (3) in 1951, True Malignant Mixed 
Tumours account for less than 1% of all Malignant Mixed 
Tumours. According to Tortoledo (4), they are biphasic 
tumours that are also able to metastasise. They can appear 
de novo, or less frequently, in existing pleomorphic ade-
nomas, though this fact does not mean that they should 
be considered CEPA. Their metastases generally contain 
an epithelial component (carcinoma) and a mesenchymal 
component (sarcoma).
Metastatic Mixed Tumours are less common. Authors 
such as Wenig (5) suggest that Metastatic Mixed Tumours 
appear after multiple recurrences of  the pleomorphic 
adenoma in the primary site and that many surgical 
manipulations can contribute to disseminate metastasis. 
Although apparently benign, mortality can be as high as 
22%, according to Ellis and Auclair (6). Other authors such 
as Fujimura (7), Minic (8) and Czader (9) suggest that this 
type of tumor could be the intermediate link in the trans-
formation of a pleomorphic adenoma into a CEPA.
The probability that a pleomorphic adenoma will become 
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malignant is directly proportional to the length of time it 
has been allowed to develop without treatment. According 
to Steifert (10), the probability of malignancy ranges from 
1.5% in the first five years to 9.5% after 15 years.                         
Case Report 
A 54-year-old female presented to our office with a left 
preauricular tumor that was 4 x 3 cm in diameter. The first 
symptoms had been observed 17 months earlier. No pain 
or facial palsy was described at that time. A fine-needle 
biopsy was performed and pleomorphic adenoma was 
diagnosed. The tumour was excised with a superficial pa-
rotidectomy that spared the facial nerve. The histopatho-
logic diagnosis of the tumor was “pleomorphic adenoma” 
(Fig.1 A,B,C,D). There was no evidence of extracapsular 
growth, atypia or vascular- perineural involvement. Mar-
gins of the surgical specimen were free of tumour.  Only 
scattered mitotic figures were present. After two years the 
patient developed a local recurrence consisting in a 3x3 
cm. tumor mass that affected the deep parotid lobe, and 
had a clinical ipsilateral neck node at level II. A total con-
servative parotidectomy with functional neck dissection 
was performed, and a diagnosis of recurrence of PA was 
made (Fig. 4A). After the second surgery on the parotid, 
the patient developed right facial palsy. The lymph node 
metastasis showed the same histological picture as the 
tumor recurrence. The patient underwent radiotherapy 
after surgery. One year later the patient was treated for 
pulmonary metastasis (Fig. 4B). The lung metastasis (Fig 
2,3) presented again the same histopathologic features as 
the primary neoplasm (Fig. 4 C&D). Five years later the 
patient died of the disease. 
Discussion
Foot e and Frazell (11) described histological benign mixed 
tumors that were invasive and could eventually metastasise 
keeping their benign cytological features from the primary 
site. It is clear that they are more uncommon than carcino-
ma in pleomorphic adenoma (CEPA). Chen (12) reported 
one case and reviewed seven others in 1978, while Ellis and 
Gnepp found only two cases that had metastasised, out 
of the many specimens in the American Forces Institute 
of Pathology (1).
Malignant mixed tumors account for 3.6% of all neo-
plasms of the salivary glands and 12% of all malignant 
neoplasms (13). The largest series published are - in order 
of  size, those of  Spiro (14), Tortoledo (4) and Livolsi 
(15).
Fig. 4. A) Low power micrograph of the local recurrence showing 
that the tumour is demarcared by a fibrous pseudocapsule. (H&E, 
50x). B) High power micrograph of another field of the local tu-
mour recurrence. The neoplasm has sheets of basaloid cells with 
little intervening myxoid stroma ( H&E, 100x );  C) Low power 
micrograph depicting the pulmonary metastasis. Lung parenchy-
ma seen adjacent to the well demarcated tumour which shows 
in the periphery higher cellularity  than in central areas, where a 
fibromyxoid stroma predominates beeing very scarce the epithelial 
cells ( H&E, 15x ); D) A field of the pulmonary metastasis that 
shows anastomosisng strands of epithelial and myoepithelial cells 
surrounded by a fibrochondroid mesenchyma (H&E, 54x ).
Fig. 1. A) Margin of the primary parotid tumour that shows 
duct-like structures. The tumour is well demarcated by a thin 
capsule of connective tissue that separate it from the parotid 
gland perenchyma ( H&E, 25x ); B) Higher magnification of a 
field of A) showing duct-like structures surrounded by a loose 
connective tissue ( H&E, 50x); C) Panoramic view of another 
field which shows ductules and strands of epithelial cells set in a 
fibromyxoid matrix ( H&E, 42x ); D)  In this field , the tumour 
has a predominant spindle cell morphology, comprised of epi-
thelial and myoepithelial cells immersed in a myxoid stroma ( 
H&E, 50x )
Fig. 2. Lateral chest X ray was done after 
cervical recurrence of  the histologically 
benign pleomorphic adenoma.
Fig. 3. CT scan showing 
multiple nodal lung me-
tastasis.
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Authors such as Czader (9) have described the metastatic 
mixed tumor as a link between a pleomorphic adenoma 
and a CEPA and suggested that metastases of pleomorphic 
adenomas may be the first stage in the transformation of 
a tumor into a carcinoma, though this does not occur in 
the majority of cases. Other authors have defended this 
hypothesis (7,8).
Metastatic PA of the salivary glands is a very infrequent 
neoplasm. Wenig et al (5) could find 32 case reports in 
the literature and added 8 new cases to their series for a 
total of 11 cases; Qureshi et al reported one case (16) and 
Czader et al one more (9). This entity has raised contro-
versy over its nomenclature and its true biological nature. 
These tumors were termed in early reports metastatic 
benign mixed tumors, a term that is a misnomer, given 
that the terms benign and metastatic are paradoxical. 
This paradox occurs also with other neoplasms of diffe-
rent organs, like the metastatic giant cell tumour of bone 
(17) and the metastasising leiomyoma of the uterus (18). 
Metastatic PA presents the same histological features 
than non-metastatic PA, showing an admixture of two 
components: An epithelial component, consisting of 
benign ductal structures and myoepithelial cells and a 
metaplasic mesenchymal appearing component, showing 
fibrous, chondroid or myxoid features. Histopathologic 
criteria as well as clinical criteria are absent. In most cases 
reported, as in our case, the patients had at least one epi-
sode of tumour recurrence at the primary site, before the 
development of metastasis, which may occur many years 
later after the presentation of the PA (5,24). Qureshi et al 
(16) reported a case in which bone metastasis appeared 16 
years after a PA of the parotid gland was treated. Usually 
metastatic PA produces haematogenous metastasis to 
the lungs, bone and other organs, although lymphatic 
metastases have been also reported (5). The percentage of 
patients dying of metastatic disease is quite high 22% (19), 
and therefore these neoplasms should not be considered 
as benign in spite that the metastatic foci show benign 
histological features. Some authors have favoured to clas-
sify metastatic PA as low-grade malignant salivary gland 
neoplasms. Unfortunately the clinical, histopathologic 
and DNA-content findings were not predictive of which 
salivary PA will metastasise and which patients will die of 
metastatic disease (19).
Some hypothesis have been raised in order to explain how 
a histological benign tumour may produce metastasis, such 
as previous radiation of the primary tumour or previous 
surgical intervention that should favour permeation of 
vessels by tumour cells, followed by metastatic spread. 
However the data reported in the literature do not support 
such hypothesis (5) having shown that they are not abso-
lute requisites for the production of metastasis.
More probably, the metastatic capability of PA reflects 
the accumulation of  key genetic alterations, since the 
malignant transformation of  neoplasms, according to 
the actual knowledge in the genesis of  tumours, is a 
sequential process in which the accumulation of genetic 
alterations causes histological and biological progression. 
For instance, the development of a carcinoma ex mixed 
tumour apparently could be, in part, the consequence of 
the accumulative loss of chromosomal loci at 3p, 9p, and 
17p (20-28).  
The order of genetic alterations along tumor progression 
is not absolute and may vary for each tumor (21), which 
would explain certain cases.  Hellquist and Michaels (22) 
reported the metachronous development of  metastasis 
to a regional lymph node and subsequent carcinoma ex 
mixed tumour in a PA. Minic (8) described a carcinoma 
ex mixed tumour that produced lymph node metastases 
in which benign and malignant histological features were 
alike present. Czader et al (9) reported a unique case of 
metastatic PA in which the patient presented a solitary kid-
ney tumour that showed the histological features of a PA 
in the absence of a previous or concurrent salivary gland 
tumour. One year after the removal of the kidney tumour, 
the patient presented an aggressive parotid tumour. After 
surgical excision the pathological examination discovered 
a high grade carcinoma arising from a PA.         
The most widely accepted procedure today is total paroti-
dectomy with conservation of the facial nerve unless this 
has been invaded by the tumor (23). Since conventional 
aspiration biopsy does not predict preoperatively how 
the tumor will behave, there is a great deal of uncertainty 
about which surgical attitude should be taken inn every 
case. 
Intraoperative confirmation is the only procedure that can 
suggest a particular therapy i.e. whether radical exeresis 
including removal of the facial nerve or neck dissection is 
needed. Radiotherapy alone is not considered to be effec-
tive. Some authors, however, do consider radiotherapy to 
be efficient as a complementary treatment (9,15).
One decisive criteria in prognosis is the infiltration of 
the margins of resection. Local recurrence, regional me-
tastasis and survival all depend on whether the margins 
are affected. In a study of 40 cases, Tortoledo (4) linked 
survival to the spread of invasion beyond the capsule in 
carcinomas ex-pleomorphic adenomas. Nourei on his 
analysis of 42 published cases of metastatic PA, revealed 
the relation between improper resection and recurrence. 
This relation is even more significant when dealing with 
carcinoma ex- pleomorphic adenomas (28)
Local recurrence makes prognosis worse and is apparently 
related to incomplete resection at first surgery. Uncontro-
lled recurrence is a risk factor for distant metastasis. This 
group of patients should be scheduled for a postoperative 
radiotherapy treatment in order to prevent possible distant 
spread. The metastatic disease, if  respectable, should be 
treated surgically (29).
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Conclusions
Metastatic pleomorphic adenoma is a very infrequent 
neoplasm. Some hypothesis have been raised in order to 
explain how a histological benign tumour may produce 
metastasis, such as previous radiation of the primary tu-
mour or previous surgical intervention that should favour 
permeation of vessels by tumour cells, followed by metas-
tatic spread.  However the data reported in the literature 
do not support such hypothesis having shown that they 
are not absolute requisites for the production of metas-
tasis. Tumour enucleation should never be performed as 
it increases local recurrence rate. Local recurrence may 
be the first step in the dissemination of these neoplasm 
and therefore radical surgery and radiotherapy should be 
considered in these cases. 
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